![](/images/graphics-bg.png)
Utility Values for Advanced Soft Tissue Sarcoma Health States from the General Public in the United Kingdom
Joint Authors
Linch, Mark
Guest, Julian F.
Sladkevicius, Erikas
Gough, Nicholas J.
Grimer, Robert J.
Source
Issue
Vol. 2013, Issue 2013 (31 Dec. 2013), pp.1-9, 9 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2013-03-17
Country of Publication
Egypt
No. of Pages
9
Main Subjects
Abstract EN
Soft tissue sarcomas are a rare type of cancer generally treated with palliative chemotherapy when in the advanced stage.
There is a lack of published health utility data for locally advanced “inoperable”/metastatic disease (ASTS), essential for calculating the cost-effectiveness of current and future treatments.
This study estimated time trade-off (TTO) and standard gamble (SG) preference values associated with four ASTS health states (progressive disease, stable disease, partial response, complete response) among members of the general public in the UK (n=207).
The four health states were associated with decreases in preference values from full health.
Complete response was the most preferred health state (mean utility of 0.60 using TTO).
The second most preferred health state was partial response followed by stable disease (mean utilities were 0.51 and 0.43, respectively, using TTO).
The least preferred health state was progressive disease (mean utility of 0.30 using TTO).
The utility value for each state was significantly different from one another (P<0.001).
This study demonstrated and quantified the impact that different treatment responses may have on the health-related quality of life of patients with ASTS.
American Psychological Association (APA)
Guest, Julian F.& Sladkevicius, Erikas& Gough, Nicholas J.& Linch, Mark& Grimer, Robert J.. 2013. Utility Values for Advanced Soft Tissue Sarcoma Health States from the General Public in the United Kingdom. Complexity،Vol. 2013, no. 2013, pp.1-9.
https://search.emarefa.net/detail/BIM-1011470
Modern Language Association (MLA)
Guest, Julian F.…[et al.]. Utility Values for Advanced Soft Tissue Sarcoma Health States from the General Public in the United Kingdom. Complexity No. 2013 (2013), pp.1-9.
https://search.emarefa.net/detail/BIM-1011470
American Medical Association (AMA)
Guest, Julian F.& Sladkevicius, Erikas& Gough, Nicholas J.& Linch, Mark& Grimer, Robert J.. Utility Values for Advanced Soft Tissue Sarcoma Health States from the General Public in the United Kingdom. Complexity. 2013. Vol. 2013, no. 2013, pp.1-9.
https://search.emarefa.net/detail/BIM-1011470
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1011470